These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9138864)

  • 1. Tissue factor pathway inhibitor: from unknown coagulation inhibitor to major antithrombotic principle.
    Lindahl AK
    Cardiovasc Res; 1997 Feb; 33(2):286-91. PubMed ID: 9138864
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor: potential therapeutic applications.
    Bajaj MS; Bajaj SP
    Thromb Haemost; 1997 Jul; 78(1):471-7. PubMed ID: 9198199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesis.
    Abildgaard U
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S45-9. PubMed ID: 7647220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor (TFPI)--an update.
    Sandset PM
    Haemostasis; 1996 Oct; 26 Suppl 4():154-65. PubMed ID: 8979119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
    Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
    Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor pathway inhibitor in thrombosis and beyond.
    Mousa SA; Fareed J; Iqbal O; Kaiser B
    Methods Mol Med; 2004; 93():133-55. PubMed ID: 14733332
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving role of tissue factor and its pathway inhibitor.
    Doshi SN; Marmur JD
    Crit Care Med; 2002 May; 30(5 Suppl):S241-50. PubMed ID: 12004243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy.
    Sajadi S; Ezekowitz MD; Dhond A; Netrebko P
    Drug News Perspect; 2003; 16(6):363-9. PubMed ID: 12973447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
    Holst J; Lindblad B; Nordfang O; Ostergaard PB; Hedner U
    Haemostasis; 1996; 26(1):23-30. PubMed ID: 8698275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor as a therapeutic target in coronary syndromes.
    Banai S; Gertz SD
    Am J Cardiol; 2001 Mar; 87(6):763-5. PubMed ID: 11249899
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.
    Abraham E
    Crit Care Med; 2000 Sep; 28(9 Suppl):S31-3. PubMed ID: 11007194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis model.
    Holst J; Lindblad B; Bergqvist D; Nordfang O; Ostergaard PB; Petersen JL; Nielsen G; Hedner U
    Haemostasis; 1993 Mar; 23 Suppl 1():112-7. PubMed ID: 8495862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirudin in disseminated intravascular coagulation.
    Nowak G; Markwardt F
    Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation.
    Velasco F; Lopez-Pedrera C; Borrell M; Fontcuberta J; Torres A
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):70-2. PubMed ID: 9105641
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue factor pathway inhibitor: clinical deficiency states.
    Sandset PM; Bendz B
    Thromb Haemost; 1997 Jul; 78(1):467-70. PubMed ID: 9198198
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
    Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
    Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.